Viewing Study NCT02609659


Ignite Creation Date: 2025-12-24 @ 3:01 PM
Ignite Modification Date: 2026-01-03 @ 4:37 AM
Study NCT ID: NCT02609659
Status: COMPLETED
Last Update Posted: 2019-12-10
First Post: 2015-11-18
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection
Sponsor: AbbVie
Organization: